ASP Isotopes (NASDAQ:ASPI) Shares Down 6.2% – Time to Sell?

ASP Isotopes Inc. (NASDAQ:ASPI) was down 6.2% during mid-day trading on Monday . The stock traded as low as $7.80 and last traded at $7.82. Approximately 833,255 shares traded hands during trading, a decline of 47% from the average daily volume of 1,586,352 shares. The stock had previously closed at $8.34.

Wall Street Analyst Weigh In

Several analysts have recently commented on ASPI shares. Canaccord Genuity Group reissued a “buy” rating and issued a $4.50 price target on shares of ASP Isotopes in a report on Friday, October 18th. Canaccord Genuity Group began coverage on shares of ASP Isotopes in a research note on Friday, October 4th. They issued a “buy” rating and a $4.50 price objective for the company. Finally, HC Wainwright dropped their price objective on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research note on Wednesday, August 7th.

ASP Isotopes Stock Performance

The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $358.38 million, a price-to-earnings ratio of -8.59 and a beta of 3.88. The stock’s 50 day moving average is $5.12 and its 200 day moving average is $3.90.

Institutional Investors Weigh In On ASP Isotopes

A number of large investors have recently bought and sold shares of the stock. KKM Financial LLC lifted its position in shares of ASP Isotopes by 66.2% in the third quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock valued at $63,000 after acquiring an additional 9,000 shares in the last quarter. Renaissance Technologies LLC grew its stake in ASP Isotopes by 5.7% in the 2nd quarter. Renaissance Technologies LLC now owns 171,800 shares of the company’s stock worth $526,000 after acquiring an additional 9,200 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in ASP Isotopes by 16.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock valued at $334,000 after acquiring an additional 17,159 shares during the last quarter. Fielder Capital Group LLC purchased a new position in shares of ASP Isotopes during the 2nd quarter worth $55,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in shares of ASP Isotopes during the third quarter worth $52,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.